Celularity Inc. (NASDAQ:CELUW) Short Interest Update

Celularity Inc. (NASDAQ:CELUW) was the target of a large growth in short interest in the month of February. As of February 27th, there was short interest totaling 1,729 shares, a growth of 219.0% from the February 12th total of 542 shares. Based on an average trading volume of 3,971 shares, the short-interest ratio is presently 0.4 days. Based on an average trading volume of 3,971 shares, the short-interest ratio is presently 0.4 days.

Celularity Trading Up 17.6%

Shares of CELUW stock opened at $0.01 on Wednesday. The company has a 50 day moving average price of $0.01 and a 200-day moving average price of $0.02. Celularity has a 52 week low of $0.01 and a 52 week high of $0.75.

About Celularity

Celularity, Inc is a clinical-stage biotechnology company headquartered in Florham Park, New Jersey, that specializes in the development and commercialization of allogeneic “off-the-shelf” cell therapies derived from postpartum placental cells. Leveraging a proprietary platform of placental- and umbilical-derived cells, the company seeks to deliver immune-modulatory, regenerative and anti-inflammatory treatments across oncology, immunology and other therapeutic areas. By harnessing the natural properties of placental cells, Celularity aims to overcome the limitations of autologous therapies and scale production to serve a broad patient population.

The company’s pipeline includes CYNK-001, an investigational natural killer (NK) cell therapy being evaluated for hematological malignancies and solid tumors, as well as other cell-based programs targeting viral infections and tissue repair.